IYH:NYE-iShares U.S. Healthcare ETF (USD)

ETF | Health |

Last Closing

USD 54.61

Change

-0.37 (-0.67)%

Market Cap

N/A

Volume

0.26M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-22 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-1.03 (-0.78%)

USD 35.08B
FHLC Fidelity® MSCI Health Care In..

-0.44 (-0.71%)

USD 2.50B
FXH First Trust Health Care AlphaD..

-0.82 (-0.81%)

USD 0.90B
XHE SPDR® S&P Health Care Equipme..

-0.37 (-0.46%)

USD 0.16B
IDNA iShares Genomics Immunology an..

+0.18 (+0.89%)

USD 0.10B
XHS SPDR® S&P Health Care Service..

-1.98 (-2.02%)

USD 0.09B
SBIO ALPS Medical Breakthroughs ETF

-0.03 (-0.12%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.01 (-0.03%)

USD 0.04B
BBP Virtus LifeSci Biotech Product..

-0.07 (-0.12%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.14 (+0.76%)

USD 0.01B

ETFs Containing IYH

RXD ProShares UltraShort Heal.. 10.32 % 0.77 %

+0.23 (+1.80%)

N/A
RXD ProShares UltraShort Heal.. 10.32 % 0.95 %

+0.23 (+1.80%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.28% 48% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.28% 48% F 27% F
Trailing 12 Months  
Capital Gain -10.18% 29% F 23% F
Dividend Return 0.92% 81% B- 19% F
Total Return -9.26% 29% F 21% F
Trailing 5 Years  
Capital Gain 27.53% 86% B+ 47% F
Dividend Return 7.10% 74% C 16% F
Total Return 34.63% 86% B+ 39% F
Average Annual (5 Year Horizon)  
Capital Gain 4.09% 76% C+ 52% F
Dividend Return 5.09% 76% C+ 47% F
Total Return 0.99% 79% B- 23% F
Risk Return Profile  
Volatility (Standard Deviation) 17.45% 48% F 56% F
Risk Adjusted Return 29.14% 71% C- 47% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.